Andon Health Co., Ltd.

Andon Health Co., Ltd. has seen a notable increase in its stock price, outperforming the China Shanghai Composite. The company has experienced significant gains over various time frames, despite facing challenges such as declining operating profit and negative results in recent quarters. Its market capitalization stands at CNY 18,799 million.

Andon Health Co., Ltd. saw a notable stock price decline today, contrasting with a minor drop in the broader market. Despite recent gains, the company faces significant financial challenges, including a sharp decrease in operating profit and net sales, alongside nine consecutive quarters of negative results. Its market capitalization remains substantial.

Andon Health Co., Ltd. saw a notable increase in its stock price on March 11, 2026, reaching an intraday high. The company's recent performance metrics indicate significant gains over various timeframes, despite facing challenges in financial results, including declines in operating profit and net profit growth.

Andon Health Co., Ltd. has seen a significant rise in its stock price, outperforming the broader market. Despite recent gains, the company faces challenges with declining operating profits and a substantial drop in net profit. With a market capitalization of CNY 18,799 million, it remains a key player in the Pharmaceuticals & Biotechnology sector.

Andon Health Co., Ltd. has experienced notable intraday gains, contrasting with a decline in the broader market. Despite a recent surge in stock performance, the company has struggled financially, reporting negative results for nine consecutive quarters, including a significant drop in net sales and profit.

Andon Health Co., Ltd. has seen a significant increase in its stock price today, contrasting with a decline in the broader market. Despite recent gains, the company faces challenges with declining net sales and profits, while showing notable long-term growth over five years. Its market capitalization stands at CNY 18,799 million.